Is Cyclerion Therapeutics Inc (CYCN) Stock Worth a Buy Tuesday?
Tuesday, September 26, 2023 10:46 AM | InvestorsObserver Analysts
Mentioned in this article
Cyclerion Therapeutics Inc (CYCN) stock has fallen -77.44% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives CYCN stock a score of 17 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 1. CYCN's rank also includes a long-term technical score of 49.
CYCN has an Overall Score of 17. Find out what this means to you and get the rest of the rankings on CYCN!
Cyclerion Therapeutics Inc (CYCN) stock has gained 2.43% while the S&P 500 has fallen -0.88% as of 10:10 AM on Tuesday, Sep 26. CYCN has gained $0.09 from the previous closing price of $3.70 on volume of 5,272 shares. Over the past year the S&P 500 is higher by 17.63% while CYCN has fallen -77.44%. CYCN lost -$13.17 per share in the over the last 12 months.
Click Here to get the full Stock Report for Cyclerion Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter